Rankings
▼
Calendar
BMRN Q4 2016 Earnings — BioMarin Pharmaceutical Inc. Revenue & Financial Results | Market Cap Arena
BMRN
BioMarin Pharmaceutical Inc.
$12B
Q4 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$300M
Gross Profit
$236M
78.6% margin
Operating Income
-$90M
-29.9% margin
Net Income
-$79M
-26.2% margin
EPS (Diluted)
$-0.53
QoQ Revenue Growth
+7.2%
Cash Flow
Operating Cash Flow
$353,000
Free Cash Flow
-$51M
Stock-Based Comp.
$37M
Balance Sheet
Total Assets
$4.0B
Total Liabilities
$1.3B
Stockholders' Equity
$2.8B
Cash & Equivalents
$408M
Revenue Segments
Product Four
$295M
64%
Product Two
$126M
27%
Product Three
$39M
8%
Product Five
$4M
1%
Geographic Segments
UNITED STATES
$142M
47%
Europe
$62M
21%
Rest Of World
$56M
19%
Latin America
$41M
14%
← FY 2016
All Quarters
Q1 2017 →
